Publications by authors named "Hilde Stevens"

Claim this Profile
I
Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation.
Sanae Akodad, Xixian Niu, Berta Secades, Hilde Stevens

Commun Med (Lond)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early access disparities in innovative therapies across the US, EU, China, and Japan.
Sanae Akodad, Michel Goldman, Hilde Stevens

Front Med (Lausanne)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Societal participation in the development of orphan drugs: a systematic review.
Sanae Akodad, Delphine De Smedt, Hilde Stevens

Front Med (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognition and communication in patients with spinal muscular atrophy: A systematic review.
Sanae Akodad, Delphine De Smedt, Simon Baijot, Hilde Stevens, Nicolas Deconinck

Heliyon· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to boost drug development in paediatric oncology.
Sam Daems, Hilde Stevens, Mathias Dewatripont, Hans-Georg Eichler, Michel Goldman

Nat Rev Drug Discov· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Rosanne Janssens, Tamika Lang, Ana Vallejo, Jayne Galinsky, Kate Morgan, Hilde Stevens

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.
Shiri Mermelstein, Hilde Stevens

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
Rosanne Janssens, Tamika Lang, Ana Vallejo, Jayne Galinsky, Ananda Plate, Hilde Stevens

Front Med (Lausanne)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions.
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, Hilde Stevens, Mark Trusheim

Drug Discov Today· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Medicine and Society.
Pietro Ghezzi, Arianne Shahvisi, Hilde Stevens

Front Med (Lausanne)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey.
Lynda Grine, Rosanne Janssens, Eline van Overbeeke, Danielle Derijcke, Mitchell Silva, Hilde Stevens

Front Med (Lausanne)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
Rosanne Janssens, Selena Russo, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Hilde Stevens

Patient· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.
Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Hilde Stevens

BMC Med Inform Decis Mak· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help?
Larissa Bolliger, Hilde Stevens

Front Med (Lausanne)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.
Rosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, Lissa Meeusen, Carolien Coenegrachts, Hilde Stevens

Front Med (Lausanne)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Approaches to Increase Access to Medicines in Developing Countries.
Hilde Stevens, Isabelle Huys

Front Med (Lausanne)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intellectual property policies in early-phase research in public-private partnerships.
Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, Isabelle Huys

Nat Biotechnol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).
Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, Isabelle Huys

Biotechnol Law Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis